This topic contains a solution. Click here to go to the answer

Author Question: A patient is being treated with quinidine to reduce automaticity. The nurse should advocate for a ... (Read 54 times)

justinmsk

  • Hero Member
  • *****
  • Posts: 524
A patient is being treated with quinidine to reduce automaticity. The nurse should advocate for a lower-than-normal dose if the patient has a history of
 
  A) type 1 or type 2 diabetes.
  B) primary hypertension.
  C) liver disease.
  D) chronic obstructive pulmonary disease.

Question 2

A women in preterm labor is being administered magnesium sulfate. The patient develops diminished reflexes and hypermagnesemia. What medication will be administered to this patient?
 
  A) Magnesium gluconate
  B) Glucose
  C) Sodium bicarbonate
  D) Calcium gluconate



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mmpiza

  • Sr. Member
  • ****
  • Posts: 354
Answer to Question 1

C
Feedback:
Hepatic impairment increases the plasma half-life of several antidysrhythmic drugs, including quinidine, and patients with hepatic impairment usually receive a reduced dosage.

Answer to Question 2

D




justinmsk

  • Member
  • Posts: 524
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


shewald78

  • Member
  • Posts: 340
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library